1 / 11

Radiopharmaceuticals Market projected to soar steadily at 5.9% CAGR, 2026

Widespread availability of SPECT and PET scanning machines will result in a growing number of radio diagnostic and radio therapeutics events in North America. For instance, the number of PET scanning machines installed per head of population in North America are more compared to that installed in Europe, thus leading to increased usage of radiotracers in the region. This growth in North America is expected to continue along with continuous technological improvements in PET scanning devices. The high level of awareness and accessibility to these machines is expected to account for high revenue generation in North America. This factor is boosting the overall growth of the global radiopharmaceuticals market. The other factor impacting the global radiopharmaceuticals market is the rising prevalence of cancer in North America. This has significantly increased the number of nuclear medicine procedures performed in the region and this is the precise reason that the market for radiopharmaceuticals is steadily growing in North America. There has been a rising number of cardiovascular diseases among the people in North America due to aging population, unhealthy food habits and rising obesity. The increasing number of cardiovascular patients is expected to boost the sales of radiopharmaceuticals, which would eventually create growth in the global radiopharmaceuticals market.<br><br>Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1992

Monica2016
Télécharger la présentation

Radiopharmaceuticals Market projected to soar steadily at 5.9% CAGR, 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Radiopharmaceuticals Market: Global Industry Analysis and Opportunity Assessment, 2016–2026 March 2017 Report Id : REP-GB-1992 Status : Feb -2017 Category : Healthcare, Pharmaceuticals & Medical Devices ©2015 Future Market Insights, All Rights Reserved

  2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework, and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Social Media Research ©2015 Future Market Insights, All Rights Reserved 2

  3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 PMR formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A PMR develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 PMR conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and PMR analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 PMR delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases ©2015 Future Market Insights, All Rights Reserved 3

  4. Radiopharmaceuticals Market Global Demand for Radiopharmaceuticals Surges with Rising Incidences of Cancer  Presence of radiopharmaceuticals in cancer medications has increased as research institutes have derived ways in which radioisotopes can impede the maturation of malignant tumour, cells and tissues.  Increasing significance of radiotracers in therapeutic care of cancer and cardiovascular diseases has also impacted the growth in demand for radiopharmaceuticals. In a recent report published by Future Market Insights, the global radiopharmaceuticals revenues in 2016 reached an estimated US$ 4,800 million value, and are anticipated to close in on US$ 8,500 million by the end of 2026. In terms of revenue, the global radiopharmaceuticals market is projected to soar steadily at 5.9% CAGR. Future Market Insights predicts that shorter half-life of radiopharmaceuticals, and lack of specified guidelines for their use in commercial-scale drug production will restrict the market from growing at higher rate. In the years to come, ageing research reactors from all corners of the world will be closed, which will significantly bring down global production of radiopharmaceuticals. With respect to sourcing these radiopharmaceuticals, the report predicts that nuclear reactors have accounted for more than 60% of global market revenues till date. Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-1992 ©2015 Future Market Insights, All Rights Reserved 4

  5. Radiopharmaceuticals Market Shutting down these reactors, however, has propelled the installation of cyclotrons, which are also a feasible source for radioisotopes. Hence, sales of radiopharmaceuticals derived from cyclotrons will continue to increase, amassing more than US$ 6,500 million by the end of 2026. Surging Demand for Technetium-99 Radioisotope Production of radiopharmaceuticals can be classified into several key radioisotopes, the prominent ones include, fluorine-18, leutetium-177, gallium-68, gallium-67 and technetium-99. In 2016, sales of radiopharmaceuticals constituting technetium-99 amassed revenues worth over US$ 2,200 million, globally. By the end of 2026, fluorine-18 radioisotope will continue to account for 16% of global radiopharmaceuticals revenues. On the other hand, global radiopharmaceutical revenues accounted by leutetium-177, gallium-68 and gallium-67, respectively, will soar at more than 6% CAGR through 2026. North America – Dominant Region for Sales of Radiopharmaceuticals Access to advanced medical facilities, highly-trained professionals and lucrative healthcare expenditure adds up to make North America the most dominant region in global radiopharmaceuticals market. North America’s radiopharmaceuticals revenues will grow at more than 6% CAGR, accounting for nearly 50% of global revenues by the end of 2026. Companies such as Positron Corporation, GE Healthcare, Mallinckrodt plc, Lantheus Holdings, Inc., and Nordion, Inc., are observed to be leading players in global radiopharmaceuticals market, and are all based across North America. ©2015 Future Market Insights, All Rights Reserved 5

  6. Radiopharmaceuticals Market Siemens Healthineers is slated to remain the most dominant company in the global radiopharmaceuticals market, accounting for over 40% of global revenues. Due to participation of Siemens and companies such as Advanced Accelerator Applications (France), Bayer AG (Germany), IBA Radiopharma Solutions (Belgium) and Eckert & Zeigler (Germany), Western Europe’s radiopharmaceuticals market is also expected to expand progressively and close in on US$ 1,600 million valuation by the end of 2026. Radiopharmaceuticals – Scope for Application & End-use  Favourable growth opportunities for radiopharmaceutical manufacturers from around the world are sited in therapeutic applications such as oncology, cardiology, neuroendocrinology, and neurology, among others.  In 2017 and beyond, consumption of radiopharmaceuticals for oncological procedures will gain traction, registering revenue growth at 6% CAGR.  On the other hand, radiopharmaceuticals consumed by neurological studies & treatment procedures will surge at the highest rate, surpassing US$ 700 million valuation by 2026-end.  Another key insight offered in the report suggests that radiopharmaceuticals used by diagnostic imaging centres will increase over the forecast period. Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 6

  7. Table of Content 1. Executive Summary 2. Market Introduction 2.1. Market Definition 2.2. Market Taxonomy 3. Global Radiopharmaceuticals Market Analysis Scenario 3.1. Market Size (US$ Mn) and Forecast 3.1.1. Market Size and Y-o-Y Growth 3.1.2. Absolute $ Opportunity 3.2. Market Overview 3.2.1. Value Chain 4. Market Dynamics 4.1. Macro-economic Factors 4.2. Drivers 4.2.1. Supply Side 4.2.2. Demand Side ©2015 Future Market Insights, All Rights Reserved 7

  8. Table of Content 4.3. Restraints 4.4. Opportunity 4.5.Forecast Factors – Relevance and Impact 4.6.Reimbursement Landscape 4.7.Regulatory Environment 4.8.Procedure Volume, By Therapeutic Area, by Region 5. Global Radiopharmaceuticals Market Analysis and Forecasts, By Radioisotope 5.1. Introduction 5.2. Basis Point Share (BPS) Analysis By Radioisotope 5.3. Y-o-Y Growth Projections By Radioisotope 5.4. Market Value Forecast By Radioisotope , 2015–2026 ©2015 Future Market Insights, All Rights Reserved 8

  9. Table of Content 5.4.1. Technetium-99 5.4.2. Fluorine-18 5.4.3. Iodine-131 5.4.4. Leutetium-177 5.4.5. Yttrium-90 5.4.6. Gallium-68 5.4.7. Gallium-67 5.4.8. Rubidium-82 5.4.9. Iodine-123 5.4.10. Indium-111 5.4.11. Others 5.5. Prominent Trends 5.6. Market Attractiveness By Radioisotope 6. Global Radiopharmaceuticals Market Analysis and Forecasts, By Application 6.1. Introduction 6.2. Basis Point Share (BPS) Analysis By Application ©2015 Future Market Insights, All Rights Reserved 9

  10. Table of Content 7. Global Radiopharmaceuticals Market Analysis and Forecasts, By Source 7.1. Introduction 7.2. Basis Point Share (BPS) Analysis By Source 7.3. Y-o-Y Growth Projections By Source 7.4. Market Value Forecast By Source , 2015–2026 7.4.1. Cyclotrons 7.4.2. Nuclear Reactors 7.5. Prominent Trends 7.6. Market Attractiveness By Source Click here to Order a free sample ©2015 Future Market Insights, All Rights Reserved 10

  11. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You ©2015 Future Market Insights, All Rights Reserved 11

More Related